Integra LifeSciences Holdings Corporation

Financials

Flujo de caja de las actividades operativas 50.74 M-11.26 M8.92 M40.91 M11.82 M 50.38 M Flujo de caja de las actividades de inversión -4.25 M-35.92 M-21.65 M-15.59 M-34.91 M -108.06 M Flujo de caja de las actividades financieras -7.15 M35.38 M-21.14 M-10.24 M24.34 M 28.34 M Flujo de caja libre 21.14 M-40.18 M-11.23 M25.75 M-5.4 M -31.05 M

Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery. Integra artificial skin became the first commercially reproducible skin tissue used to treat severe burns and other skin wounds.

IART

Financials

Integra LifeSciences Holdings Corporation

Noticias

Neuronetics nombra a Dan Reuvers como CEO a partir del 23 de marzo

Should You Continue to Hold Integra Stock in Your Portfolio Now?

Integra Q4 Earnings & Revenues Beat Estimates, Margins Down, Stock Up

Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term

Integra T4 2025: resultados mixtos con presión en márgenes pese a avances

Integra Q4 2025 slides: mixed results as margin pressure offsets progress

Integra (IART) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates

Integra superaron 0.03$ las previsiones de BPA en el cuarto trimestre del año

Integra LifeSciences supera estimados pero guía bajo consenso

Integra LifeSciences beats estimates but guides below consensus

Integra LifeSciences appoints new CTO and key executives